IL1RL1 variant may affect the response to type 2 biologics in patients with severe asthma

IL1RL1 variant may affect the response to type 2 biologics in patients with severe asthma

Background Asthma is a heterogeneous disease with variable response to treatment. Genetic backgrounds are involved in the severity of type 2 asthma, but their effects on responses to biologics remain unknown. This study aimed to clarify the role of genetic factors in response to biologics in patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Kenta Nishi, Hisako Matsumoto, Hironobu Sunadome, Tadao Nagasaki, Tsuyoshi Oguma, Noriyuki Tashima, Yusuke Hayashi, Satoru Terada, Kyohei Morita, Chie Yoshimura, Yasuo Nishizaka, Akiko Sano, Takashi Iwanaga, Hiroyuki Sano, Ryuta Haraguchi, Yuji Tohda, Takahisa Kawaguchi, Fumihiko Matsuda, Toyohiro Hirai
Format: Article
Language:English
Published: European Respiratory Society 2025-01-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/11/1/00448-2024.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://openres.ersjournals.com/content/11/1/00448-2024.full

Similar Items